| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| 2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-methoxy-4-methyl-6,8-dioxo-, (4R,12aR)- |
多替拉韋/巴洛沙韋雜質(zhì)D32-001 |
2384108-28-3 |
詳細(xì)
|
| 1-Propanamine, N-methyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]- |
芐達(dá)明雜質(zhì)B18-001 |
32852-16-7 |
詳細(xì)
|
| 2-[3-(Dimethylamino)propyl]-1,2-dihydro-1-(phenylmethyl)-3H-indazol-3-one |
芐達(dá)明雜質(zhì)B18-002 |
52413-42-0 |
詳細(xì)
|
| 1,3-Propanediamine, N1,N1,N3-trimethyl-N3-[3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]propyl]- |
芐達(dá)明雜質(zhì)B18-003 |
1337966-15-0 |
詳細(xì)
|
| NA |
哌柏西利雜質(zhì)P03-003 |
362658-21-7 |
詳細(xì)
|
| INDEX NAME NOT YET ASSIGNED |
哌柏西利雜質(zhì)P03-011 |
2399424-46-3 |
詳細(xì)
|
| 6-acetyl-2-aMino-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one |
哌柏西利雜質(zhì)P03-020 |
571189-64-5 |
詳細(xì)
|
| 1,3-Dioxol-2-one, 4,5-bis(hydroxymethyl)- |
美阿沙坦鉀雜質(zhì)M02-002 |
1417576-03-4 |
詳細(xì)
|
| 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy- |
美阿沙坦鉀雜質(zhì)M02-003 |
1234834-29-7 |
詳細(xì)
|
| 4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-6-phenyl-, 5-oxide |
艾司唑侖雜質(zhì)A18-001 |
29975-18-6 |
詳細(xì)
|
| N'-[[(2-benzoyl-4-chlorophenyl)(chloroacetyl)amino]methylene]chloroacetohydrazide |
艾司唑侖雜質(zhì)A18-002 |
49691-65-8 |
詳細(xì)
|
| 2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-phenyl-, hydrazone, (Z)- (9CI) |
艾司唑侖雜質(zhì)A18-003 |
112393-62-1 |
詳細(xì)
|
| (5aR,10aR)-1,2,3,5a,6,7,8,10a-octahydrodipyrrolo[1,2-c:1',2'-f]pyrazine-5,10-dione |
L-脯氨酸雜質(zhì)P16-002 |
53990-71-9 |
詳細(xì)
|
| 2-Hexenoic acid, 4,5-dihydroxy-, (2E,4S,5R)- |
左卡尼汀雜質(zhì)Z01-001 |
931426-06-1 |
詳細(xì)
|
| 2-Hexenoic acid, 4,5-dihydroxy- |
左卡尼汀雜質(zhì)Z01-002 |
873385-02-5 |
詳細(xì)
|
| (11β,17Z)-11,20-Dihydroxy-3-oxo-pregna-4,17(20)-dien-21-al |
氫化可的松雜質(zhì)Q02-001 |
105562-13-8 |
詳細(xì)
|
| (11β,17E)-11,20-dihydroxy-3-oxo-pregna-4,17(20)-dien-21-al |
氫化可的松雜質(zhì)Q02-002 |
105562-12-7 |
詳細(xì)
|
| Propanoic acid, 2-[[(Z)-[1-(2-amino-4-thiazolyl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methyl-, 1-(1,1-dimethylethyl) ester |
氨曲南雜質(zhì)A25-004 |
330944-50-8 |
詳細(xì)
|
| Carbidopa Methyl Ester |
卡比多巴雜質(zhì)K02-001 |
91431-01-5 |
詳細(xì)
|
| Carbidopa Ethyl Ester |
卡比多巴雜質(zhì)K02-002 |
91908-71-3 |
詳細(xì)
|
| riboflavin 3',5'-bisphosphate |
核黃素雜質(zhì)H01-001 |
86108-26-1 |
詳細(xì)
|
| Riboflavin 4’,5’-Diphosphate |
核黃素雜質(zhì)H01-002 |
86108-25-0 |
詳細(xì)
|
| 1487411-82-4 |
阿昔替尼雜質(zhì)A13-001 |
1487411-82-4 |
詳細(xì)
|
| Butanoic acid, 2-[(4-cyano-2-methoxyphenyl)methylene]-3-oxo-, ethyl ester |
非奈利酮雜質(zhì)F06-003 |
959934-80-6 |
詳細(xì)
|
| Finerenone impurity 34 |
非奈利酮雜質(zhì)F06-005 |
2924224-42-8 |
詳細(xì)
|
| 2-Cyanoethyl (2E)-2-[(4-cyano-2-methoxyphenyl)methylene]-3-oxobutanoate |
非奈利酮雜質(zhì)F06-012 |
1870824-79-5 |
詳細(xì)
|
| Bedaquiline Impurity 5 |
貝達(dá)喹啉雜質(zhì)B06-001 |
916801-19-9 |
詳細(xì)
|
| 2-amino-4-ethyl-5-methylbenzene-1,3-dicarbonitrile |
奧氮平雜質(zhì)A33-009 |
55525-92-3 |
詳細(xì)
|
| N-Formyl-5-asa |
氨氯地平雜質(zhì)A24-023 |
104786-99-4 |
詳細(xì)
|
| Ethyl diazophenylacetate |
格隆溴銨雜質(zhì)G05-011 |
22065-57-2 |
詳細(xì)
|
| Propanamide, 2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]hydroxyamino]-, (2S)- |
沙芬酰胺雜質(zhì)S03-006 |
2270245-27-5 |
詳細(xì)
|
| Mirabegron Impurity Q |
米拉貝隆雜質(zhì)M09-002 |
1684452-92-3 |
詳細(xì)
|
| 1-Piperazinecarbonyl chloride (9CI) |
佐匹克隆雜質(zhì)Z04-001 |
69433-07-4 |
詳細(xì)
|
| Benzoic acid, 4-hydroxy-, 4-carboxyphenyl ester |
丙泊酚雜質(zhì)B21-001 |
40677-31-4 |
詳細(xì)
|
| Pentanedioic acid, 3-(3-furanyl)- |
納呋拉啡雜質(zhì)N01-001 |
2228413-62-3 |
詳細(xì)
|
| DICHLORO-N-METHYLACETAMIDE |
他達(dá)那非雜質(zhì)T01-001 |
5345-73-3 |
詳細(xì)
|
| Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]-2-propoxyphenyl]-5-methyl-7-propyl- |
伐地那非雜質(zhì)F01-001 |
1339092-18-0 |
詳細(xì)
|
| Benzenepropanamine, N-hydroxy-N-methyl-γ-[4-(trifluoromethyl)phenoxy]- |
氟西汀雜質(zhì)F13-001 |
1624625-05-3 |
詳細(xì)
|
| Hydrazine amide of deoxycholic acid |
去氧膽酸雜質(zhì)Q13-001 |
96840-44-7 |
詳細(xì)
|
| DL-METHIONINE-D3 |
蛋氨酸雜質(zhì)D06-002 |
284665-20-9 |
詳細(xì)
|
| 2H-Pyrrole-2-carboxylicacid,5-amino-3,4-dihydro-,(S)-(9CI) |
呱侖酸鈉雜質(zhì)G06-001 |
111631-17-5 |
詳細(xì)
|
| sodium dihydrogen 2-sulphonatosuccinate |
琥珀酸鈉雜質(zhì)H02-001 |
29454-16-8 |
詳細(xì)
|
| estradiol 17-sulfate |
雌二醇雜質(zhì)C02-001 |
3233-69-0 |
詳細(xì)
|
| (R)-4,5-Dehydro Pregabalin |
普瑞巴林雜質(zhì)P15-001 |
1101167-84-3 |
詳細(xì)
|
| 2(1H)-Pyridinone, 1-(2-chlorophenyl)-5-methyl- |
吡非尼酮雜質(zhì)B14-001 |
1198414-06-0 |
詳細(xì)
|
| 2(1H)-Pyrimidinone,4-amino-1-b-D-arabinofuranosyl-, 3-oxide |
阿糖胞苷雜質(zhì)A09-001 |
30902-36-4 |
詳細(xì)
|
| Cytarabine Impurity 10 |
阿糖胞苷雜質(zhì)A09-002 |
84902-98-7 |
詳細(xì)
|
| 1,3,5-Triazine-2,4-diamine, 3,6-dihydro-N2,N2,6-trimethyl-, hydrochloride (1:1) |
依格列明雜質(zhì)Y07-001 |
352211-11-1 |
詳細(xì)
|
| 7H,14H-Pyrazino[1,2-b:4,5-b]diindazole-7,14-dione |
格拉司瓊雜質(zhì)G04-001 |
115660-68-9 |
詳細(xì)
|
| Metronidazole Impurity 3 |
甲硝唑雜質(zhì)J06-007 |
5006-79-1 |
詳細(xì)
|
| Benzamide, 3-amino-4-(methylamino)-N-[3-oxo-3-(2-pyridinylamino)propyl]-N-2-pyridinyl- |
達(dá)比加群酯雜質(zhì)D01-007 |
2931469-64-4 |
詳細(xì)
|
| N-(4-cyanophenyl)-2-((4-cyanophenyl)amino)acetamide |
達(dá)比加群酯雜質(zhì)D01-008 |
1900865-84-0 |
詳細(xì)
|
| Dabigatran impurity 73 |
達(dá)比加群酯雜質(zhì)D01-010 |
858967-80-3 |
詳細(xì)
|
| 3-[(4-chloro-3-nitrobenzoyl)pyridin-2-yl-amino]propionic acid ethyl ester |
達(dá)比加群酯雜質(zhì)D01-012 |
1620205-04-0 |
詳細(xì)
|
| Bedaquiline Impurity 13 |
貝達(dá)喹啉雜質(zhì)B06-002 |
2122862-01-3 |
詳細(xì)
|
| (5alpha)-4,5-Epoxy-3,14-dihydroxy-6-oxomorphinan-17-carboxaldehyde |
納美芬雜質(zhì)N02-001 |
1007856-83-8 |
詳細(xì)
|
| Nalmefene Impurity |
納美芬雜質(zhì)N02-002 |
738552-29-9 |
詳細(xì)
|
| Naltrexone EP Impurity H |
納美芬雜質(zhì)N02-003 |
503090-99-1 |
詳細(xì)
|
| Impurity |
坎地沙坦酯雜質(zhì)K05-001 |
1821385-89-0 |
詳細(xì)
|
| 2-Ethoxy-1-(tetrazolo[1,5-f]phenanthridin-6-ylmethyl)-1H-benzimidazole-7-carboxylic acid |
坎地沙坦酯雜質(zhì)K05-002 |
1821386-35-9 |
詳細(xì)
|
| 2-Cyclohexen-1-one, 5-(4-chlorophenyl)-3-methyl- |
巴氯芬雜質(zhì)B02-007 |
54795-01-6 |
詳細(xì)
|
| 2-(Sodiooxy)-1-cyclopentene-1-carboxylic acid methyl ester |
洛索洛芬雜質(zhì)L19-001 |
63178-03-0 |
詳細(xì)
|
| Brimonidine Impurity 14 |
溴莫尼定雜質(zhì)X10-006 |
934548-66-0 |
詳細(xì)
|
| 4-((2-amino-2-oxoethyl)amino)butanoic acid |
吡拉西坦雜質(zhì)B16-001 |
1096803-44-9 |
詳細(xì)
|
| 3-Furancarbonitrile, 2-amino-5-(2-fluorophenyl)- |
沃諾拉贊/伏諾拉生雜質(zhì)W01-001 |
312307-69-0 |
詳細(xì)
|
| Isoquinolinium, 2-[3-[[(4E)-7-carboxy-1-oxo-4-hepten-1-yl]oxy]propyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-, chloride (1:1), (1R,2S)- |
米庫(kù)氯銨雜質(zhì)M08-006 |
161816-38-2 |
詳細(xì)
|
| Lomefloxacin Impurity 3 |
洛美沙星雜質(zhì)L18-007 |
183235-15-6 |
詳細(xì)
|
| 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid ethyl ester |
洛美沙星雜質(zhì)L18-008 |
98079-83-5 |
詳細(xì)
|
| 2-Imidazolidinecarboxamide, N-(2,6-dimethylphenyl)-4-methyl-1-(2-methylphenyl)-5-oxo-3-propyl- |
丙胺卡因雜質(zhì)B19-014 |
2509057-86-5 |
詳細(xì)
|
| Ketoprofen Impurity 15 |
酮洛芬雜質(zhì)T07-010 |
1257296-76-6 |
詳細(xì)
|
| 2,4-Furandiol, tetrahydro-2-(hydroxymethyl)- |
乳果糖雜質(zhì)R01-001 |
136272-61-2 |
詳細(xì)
|
| Dobutamine Impurity 6 |
多巴酚丁胺雜質(zhì)D27-005 |
140165-60-2 |
詳細(xì)
|
| NA |
多巴酚丁胺雜質(zhì)D27-006 |
|
詳細(xì)
|
| NA |
多巴酚丁胺雜質(zhì)D27-007 |
|
詳細(xì)
|
| 4-METHYL-3-[[1-OXO-2-(PROPYLAMINO)PROPYL]AMINO]-2-THIOPHENECARBOXYLIC ACID |
阿替卡因雜質(zhì)A10-011 |
114176-52-2 |
詳細(xì)
|
| Lomefloxacin Impurity |
洛美沙星雜質(zhì)L18-009 |
111234-01-6 |
詳細(xì)
|
| Lomefloxacin Impurity 8 |
洛美沙星雜質(zhì)L18-010 |
195259-19-9 |
詳細(xì)
|
| Lomefloxacin Impurity |
洛美沙星雜質(zhì)L18-012 |
195259-11-1 |
詳細(xì)
|
| Dabigatran Impurity i |
達(dá)比加群酯雜質(zhì)D01-013 |
1354892-78-6 |
詳細(xì)
|
| 1H-Pyrrole-2,5-dione, 3,4-bis(hydroxymethyl)- |
維生素B6雜質(zhì)W03-001 |
2775363-46-5 |
詳細(xì)
|
| 3,4-Pyridinedimethanol,5-hydroxy-6-methyl-, 1-oxide |
維生素B6雜質(zhì)W03-002 |
16567-04-7 |
詳細(xì)
|
| Pyridoxine Impurity 9 |
維生素B6雜質(zhì)W03-003 |
1385767-86-1 |
詳細(xì)
|
| Pyridoxine Impurity 5 |
維生素B6雜質(zhì)W03-004 |
412940-03-5 |
詳細(xì)
|
| Benzoic acid, 3-[[[(2S,4S)-4-hydroxy-2-pyrrolidinyl]carbonyl]amino]- |
厄他培南雜質(zhì)E01-001 |
266337-30-8 |
詳細(xì)
|
| Benzoic acid, 3-[[[(2S,4R)-4-hydroxy-2-pyrrolidinyl]carbonyl]amino]- (9CI) |
厄他培南雜質(zhì)E01-002 |
770703-11-2 |
詳細(xì)
|
| 3-Thiophenecarboxylic acid, 4-formyl-2,5-dihydro-2-(4-hydroxybutylidene)-5-methyl-, (2Z)- |
法羅培南雜質(zhì)F02-001 |
1025974-23-5 |
詳細(xì)
|
| Hydrazinecarboxamide, 1-[(1S,2S)-1-ethyl-2-(phenylmethoxy)propyl]-2-formyl-N-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- |
泊沙康唑雜質(zhì)P11-003 |
2889357-64-4 |
詳細(xì)
|
| 161532-54-3 |
泊沙康唑雜質(zhì)P11-005 |
161532-54-3 |
詳細(xì)
|
| 4-(4-{4-[(3R,5R)-5-(2,4-DIFLUORO-PHENYL)-5-[1,2,4]TRIAZOL-1-YLMETHYL-TETRAHYDRO-FURAN-3-YLMETHOXY]-PHENYL}-PIPERAZIN-1-YL)-PHENYLAMINE |
泊沙康唑雜質(zhì)P11-006 |
184378-04-9 |
詳細(xì)
|
| LROQBKNDGTWXET-FVWDGWMTSA-N |
加蘭他敏雜質(zhì)J03-004 |
199014-26-1 |
詳細(xì)
|
| 3-(2-Amino-1-chloropropyl)phenol |
間羥胺雜質(zhì)J11-003 |
1379208-51-1 |
詳細(xì)
|
| NQT Impurity E |
納曲酮雜質(zhì)N03-002 |
767615-69-0 |
詳細(xì)
|
| Naltrexone 3-Methyl Ether |
納曲酮雜質(zhì)N03-003 |
16617-07-5 |
詳細(xì)
|
| Naltrexone EP Impurity C |
納曲酮雜質(zhì)N03-004 |
189016-90-8 |
詳細(xì)
|
| 5-Benzamido-4-oxopentanoic acid |
氨酮戊酸雜質(zhì)A26-002 |
102872-00-4 |
詳細(xì)
|
| 6-Hydroxy-2-naphthamide |
萘莫司他雜質(zhì)N06-001 |
62529-01-5 |
詳細(xì)
|
| 2H-Pyrido[1,2-a]pyrazine-7-carboxylic acid, 1,8-dihydro-2-[(1R)-3-hydroxy-1-methylpropyl]-9-methoxy-1,8-dioxo- |
多替拉韋雜質(zhì)D31-002 |
2710626-41-6 |
詳細(xì)
|
| 2,5-Pyridinedicarboxylic acid, 1-(2,2-dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo- |
多替拉韋雜質(zhì)D31-003 |
2651309-06-5 |
詳細(xì)
|
| Ibrutinib Impurity 14 |
伊布替尼雜質(zhì)Y02-001 |
2417548-76-4 |
詳細(xì)
|
| 1,3-Benzodioxole, 5,5'-methylenebis- |
吡貝地爾雜質(zhì)B13-011 |
4971-68-0 |
詳細(xì)
|